Drug intelligence / Profile preview

compound psoralen

Development stage
Unknown
Lead developer
Chongqing Kerui Pharmaceutical
Administration
Oral
01

Overview

Compound psoralen (also known as Compound Psoralen granules or Fufang Buguzhi Keli) is a traditional Chinese medicine (TCM) preparation developed and manufactured by Chongqing Kerui Pharmaceutical. It is formulated as oral granules containing a mixture of herbal extracts, including *Psoralea corylifolia* (Buguzhi), *Cynomorium songaricum* (Suoyang), *Dipsacus asper* (Xuduan), *Cibotium barometz* (Gouji), *Paeonia lactiflora* (Chishao), and *Polygonatum sibiricum* (Huangjing). Compound psoralen is approved in China for the treatment of conditions associated with Kidney Yang deficiency, including lumbar muscle strain, degenerative lumbar spine disease, and lumbar and knee pain. It works by warming and tonifying the liver and kidney, strengthening bones and muscles, promoting blood circulation, and relieving pain.

Brand names
KeruiRuidongSenggukang圣固康瑞东科瑞
Other names
Compound Psoralen GranuleCompound Psoralen granulesFufang Buguzhi Keli复方补骨脂颗粒
02

Targets

CYP2A6 (Cytochrome P450 2A6)DNAERBB2 (Erb-b2 receptor tyrosine kinase 2)MAOA (Monoamine oxidase A)MAOB (Monoamine oxidase B)

Beyond the preview

Go deeper on compound psoralen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound psoralen.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call